Hokkaido University · Faculty of Medicine / Graduate School of Medicine / Medical Research Institute

Research keywordsacute myeloid leukemia・myelodysplasia-related AML・allogeneic stem cell transplantation・umbilical cord blood transplantation・graft-versus-host disease prophylaxis・hematologic malignancy・transplant outcomes・thrombocytopenia after transplantation

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Safety and Efficacy of Graft-versus-Host Disease Prophylaxis with Mini-Dose Methotrexate in Umbilical Cord Blood Transplantation: An NJHSG-CBT18 Observational Study2026 · Transplantation and Cellular Therapy, 2026年03月
• Adverse karyotype amplifies risk in secondary acute myeloid leukemia (AML) and AML with myelodysplasia-related changes2026 · Hematology, 2026年12月31日
• Perioperative pharmacokinetics of lenacapavir during massive hemorrhage in a patient with hemophilia a undergoing liver transplantation2026 · Journal of Infection and Chemotherapy, 2026年06月
• Comparable outcomes with 14-, 21-, or standard 28-day venetoclax in the first cycle of azacitidine-venetoclax in untreated acute myeloid leukemia: real-world experience from the Hokkaido Leukemia Net.2025 · Blood cancer journal, 15, 1, 118, 118, 2025年07月03日,

• Official profile